返回
Haleon PLC（HLNCF）价格
HLNCF 股价走势图
HLNCF 财务
Haleon PLC
$5.05
4.88%
$0.23
收盘价：Jan 20, 16:00:00 GMT-5
$4.8
-4.95%
$-0.25
盘后：Jan 20, 17:07:20 GMT-5
关键数据
前收盘价
$4.81
开盘价
$4.9
当日区间
$4.8 - $5.07
52周范围
$4.25 - $5.8
交易量
200
平均成交量
14.2K
每股收益（TTM）
0.22
股息收益率
--
市值
$21.3B
什么是 HLNCF？
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.